544694 — Accretion Nutraveda Income Statement
0.000.00%
Last trade - 00:00- IN₹1.28bn
- IN₹1.32bn
- IN₹160.02m
Annual income statement for Accretion Nutraveda, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 5.85 | 29 | 50.1 | 160 |
| Cost of Revenue | ||||
| Gross Profit | 2.4 | 12 | 21.4 | 54.3 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 7.79 | 25.9 | 40.4 | 125 |
| Operating Profit | -1.94 | 3.1 | 9.63 | 34.8 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -3.69 | 2.87 | 9.15 | 31.8 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -3.84 | 2.81 | 8.05 | 26.1 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -3.84 | 2.81 | 8.05 | 26.1 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -3.84 | 2.81 | 8.22 | 26.1 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.531 | 0.388 | 1.14 | 3.61 |